Antifungal activity of new derivatives of 4-(het)aryl-2,4-dioxobutanoic acids

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Among more than 600 types of micromycetes of clinical importance, fungi of the Candida spp. are the most common pathogen, causing different forms of candidiasis (superficial candidiasis, visceral candidiasis). The aim of this work was to determine the antifungal activity of new derivatives of 4-(het)aryl-2,4-dioxobutanoic acids, in relation to typical strains of Candida yeast and to identify the most active compounds. The study of the antifungal activity of the compounds was carried out by the micromethod of double serial dilutions in a liquid medium. The antifungal activity of 6 compounds in relation to 4 typical strains of Candida spp. was studied; the high antimycotic activity of 4 compounds against the Candida albicans strain was established. A leader compound with high antifungal activity for all the studied strains was revealed. The prospects of studying the modified compounds of this series are shown.


Full Text

Restricted Access

About the authors

Valentina V. Novikova

Perm State Pharmaceutical Academy

Author for correspondence.
Email: vvnperm@yandex.ru

Russian Federation, Perm

MD, PhD, Аssociate Professor, Head of the Department of Microbiology

Natalya A. Pulina

Perm State Pharmaceutical Academy

Email: pulina.natalya@pfa.ru

Russian Federation, Perm

MD, PhD, DSci (Pharmacy), Professor, Head of the Department of Pharmaceutical Technology

Fedor V. Sobin

Perm State Pharmaceutical Academy

Email: fff-2005@mail.ru

Russian Federation, Perm

PhD, Associate Professor, Department of Pharmaceutical Technology

Konstantin V. Lipatnikov

Perm State Pharmaceutical Academy

Email: lkv2901@mail.ru

Russian Federation, Perm

PhD, Associate Professor, Department of Pharmaceutical Technology

References

  1. Index Fungorum. Indexfungorum.org [Internet]. Available from: http://www.indexfungorum.org/names/names.asp. Cited 2020 Aug 2.
  2. Аравийский Р.А., Климко Н.Н., Горшкова Г.И. Диагностика микозов. rusmedserv.ru [интернет]. Доступно по: http://www.rusmedserv.com/mycology/html/labor9.htm. Ссылка активна на 02.08.2020. [Araviyskiy RA, Klimko NN, Gorshkova GI. Diagnostika mikozov Rusmedserv [Internet]. Available from: http://www.rusmedserv.com/mycology/html/labor9.htm. Cited 2020 Aug 2. (In Russ.)]
  3. Климко Н.Н., Козлова Я.И., Хостелиди С.Н., и др. Распространенность тяжелых и хронических микотических заболеваний в Российской Федерации по модели LIFE program // Проблемы медицинской микологии. – 2014. – Т. 16. – № 1. – С. 3–8. [Klimko NN, Kozlova YaI, Khostelidi SN, et al. The prevalence of severe and chronic mycotic diseases in Russian Federation on LIFE program model. Problems in medical mycology. 2014;16(1):3-8. (In Russ.)]
  4. Прилепская В.Н., Байрамова Г.Р. Вульвовагинальный кандидоз. Клиника, диагностика, принципы терапии. – М.: ГЭОТАР-Медиа, 2010. [Prilepskaya VN, Bayramova GR. Vul’vovaginal’nyy kandidoz. Klinika, diagnostika, printsipy terapii. Moscow: GEOTAR-Media; 2010. (In Russ.)]
  5. Najwan AM, Nemat JA, Hamzia AA. Epidemiological Study of Candida Species among Vaginal and Oral Candidiasis from different clinical states. Int J Chemtech Res. 2017;10(5):844-857.
  6. Розанова С.М., Шилова В.П., Перевалова Е.Ю., и др. Этиология госпитальных инфекций в ОРИТ Екатеринбурга — тенденции 2007 года // Интенсивная терапия. – 2008. – Т. 17. – № 2. [Rozanova SM, Shilova VP, Perevalova EYu, et al. Etiologiya gospital’nykh infektsiy v ORIT Ekaterinburga – tendentsii 2007 goda. Intensivnaya terapiya. 2008;3(2). (In Russ.)]
  7. Байрамова Г.Р. Рецидивирующий вульвовагинальный кандидоз: клиника, диагностика, лечение: Автореферат дис. … д-ра мед. наук. – М., 2013. [Bayramova GR. Retsidiviruyushchiy vul’vovaginal’nyy kandidoz: klinika, diagnostika, lechenie. [dissertation] Moscow; 2013. (In Russ.)]
  8. Малова И.О., Кузнецова Ю.А. Чувствительность к антимикотикам Candida spp., выделенных от пациенток с хроническим рецидивирующим кандидозом урогенитального тракта // Проблемы медицинской микологии. – 2013. – Т. 15. – № 2. – С. 103–104. [Malova IO, Kuznetsova YuA. Chuvstvitel’nost’ k antimikotikam Candida spp., vydelennykh ot patsientok s khronicheskim retsidiviruyushchim kandidozom urogenital’nogo trakta. Problemy meditsinskoy mikologii. 2013;15(2):103-104. (In Russ.)]
  9. Marchaim D, Lemanek L, Bheemreddy, et al. Fluconazole-Resistant Candida albicans Vulvovaginitis. Obstet Gynecol. 2012;120(6):1407-1414. https://doi.org/10.1097/aog.0b013e31827307b2.
  10. Clinical and Laboratory Standards Institute. М27-АЗ, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard – Third Edition. Wayne: CLSI; 2008.
  11. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST Definitive Document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clinl Microbiol Infect. 2008;14(4):398-405. https://doi.org/10.1111/j.1469-0691.2007.01935.x.
  12. Brandolt TM, Klafke GB, Gonçalves CV, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol. 2017;48(1): 145-150. https://doi.org/10.1016/j.bjm.2016.09.006.
  13. Новикова В.В., Гейн В.Л. Углубленное исследование противогрибковой активности соединений ряда серебряных солей пиразол-3-карбоксамидов // Антибиотики и химиотерапия. – 2018. – Т. 63. – № 9–10. – С. 10–13. [Novikova VV, Gein VL. In-Depth Investigation of Antifungal Activity of Compounds of Series of Silver Salts of Pyrazol-3-Carboxamids. Antibiotics and chemotherapy. 2018;63(9-10):10-13. (In Russ.)]
  14. Новикова В.В., Русских А.А. Исследование противогрибковой активности нового соединения ряда серебряных солей пиразол-3-карбоксамидов in vitro // Разработка и регистрация лекарственных средств. – 2018. – № 2. – С. 92–95. [Novikova VV, Russkih AA. The investigation of antifungal activity of new silver salt of pyrazol-3-carboxamides in vitro. Razrabotka i registratsiya lekarstvennykh sredstv. 2018;(2):92-95. (In Russ.)]
  15. Новикова В.В., Гейн В.Л., Бобровская О.В. Антимикотическая активность новых серебряных солей пиразол-3-карбоксамидов // Проблемы медицинской микологии. – 2017. – Т. 19. – № 3. – С. 64–66. [Novikova VV, Gein VL, Bobrovskaya OV. Antimycotic activity of new silver salts of pyrazole-3-carboxamides. Problems in medical mycology. 2017;19(3);64-66. (In Russ.)]
  16. Пулина Н.А., Собин Ф.В., Краснова А.И. Изучение биологической активности новых производных 5-арил-1-R-1H-пиразол-3-карбоновых кислот // Вестник Уральской медицинской академической науки. – 2011. – № 3. – С. 70–71. [Pulina NA, Sobin FV, Krasnova AI. Study of biological activity of new derivatives of 5-aryl-1-R-1H-pyrazol-3-carboxylic acids. Journal of Ural medical academic science. 2011;(3):70-71. (In Russ.)]
  17. Пулина Н.А., Краснова А.И., Собин Ф.В., и др. Направленный синтез и поиск фармацевтических субстанций гипогликемического действия в ряду производных 4-арил-2-гидрокси-4-оксо-2-бутеновых кислот // Бюллетень сибирской медицины. – 2011. – Т. 10. – № 5. – С. 86–90. [Pulina NA, Krasnova AI, Sobin FV, et al. Directed synthesis and search of pharmaceutical substances with hypoglycemic activity in the series of 4-aryl-2-hydroxy-4-oxo-2-butenoic acids. Bulletin of Siberian medicine. 2011;10(5):86-90. (In Russ.)]
  18. Pulina NA, Sobin FV, Yushkova TA, et al. Synthesis and biological activity of new 1,3-benzothiazole derivatives. Pharmaceutical Chemistry Journal. 2014;48(8):505-508. https://doi.org/10.1007/s11094-014-1139-y.
  19. Pulina NA, Sobin FV, Lipatnikov KV, et al. Synthesis and biological activity of 4-aryl-N-(5,6-R-benzo[d]thiazol-2-yl)-2-hydroxy-4-oxobut-2-enamides. Russian Journal of General Chemistry. 2018;88(8):1618-1622. https://doi.org/10.1134/S107036321808011X.
  20. Pulina NA, Sobin FV, Yushkova TA, Novikova VV. Reactions of 4-aryl-N-hetaryl-2-hydroxy-4-oxobut-2-enamides with hydroxylamine and biological activity of the products. Russian Chemical Bulletin. 2019;68(3):628-633. https://doi.org/10.1007/s11172-019-2466-7.
  21. Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии. Определение чувствительности микроорганизмов к антимикробным препаратам. Клинические рекомендации. 2018. [Interregoional association for clinical microbiology and antimicrobial chemotherapy. Opredelenie chuvstvitelnosti mikroorganizmov k antimikrobnym preparatam. Klinicheskie rekomendatsii. 2018. (In Russ.)]
  22. Руководство по проведению доклинических исследований лекарственных средств. Часть первая / под ред. А.Н. Миронова. – М.: Гриф и К, 2012. [Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Ed. by A.N. Mironov. Moscow: Grif i K; 2012. (In Russ.)]
  23. De Vita D, Scipione L, Tortorellaa S, et al. Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives. Eur J Med Chem. 2012;49:334-342. https://doi.org/10.1016/j.ejmech.2012.01.034.

Statistics

Views

Abstract - 46

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2020 Novikova V.V., Pulina N.A., Sobin F.V., Lipatnikov K.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies